News

Q1 2023 Newsletter – Recombinant metabolising enzymes

Hypha’s Q1 2023 newsletter – Recombinant metabolising enzymes

In our Q1 2023 newsletter we focus on Hypha’s recombinant enzymes, in particular new innovations to our PolyCYPs platform.

Biotransformation of pirfenidone to an oxidised metabolite which matches the CYP1A2 product.

More News

MetID Services Launch

Launch of New MetID Services Hypha Discovery is excited to announce that we have extended our metabolite identification services to include LC-MS/MS-based MetID, complementing our

Q1 2025 – Launch of PolyUGTs Kits

Launch of PolyUGTs Kits Our PolyUGTs screening and scale-up kits are now available! They’re a super easy way to make glucuronides for MetID and testing

Welcome to Matt and Xianfu

Welcome to Matt and Xianfu We are delighted that Matthew Allen and Xianfu Li have joined Hypha’s team recently. Xianfu was previously at Evotec and specialises in metabolite

Ready to begin? Our scientists are available to talk through your requirements

Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.

News

Q1 2023 Newsletter – Recombinant metabolising enzymes

Hypha’s Q1 2023 newsletter – Recombinant metabolising enzymes

Biotransformation of pirfenidone to an oxidised metabolite which matches the CYP1A2 product.

More News

MetID Services Launch

Q1 2025 – Launch of PolyUGTs Kits

Welcome to Matt and Xianfu

Ready to begin? Our scientists are available to talk through your requirements

What We Do

Our Products

Our Science

Resources

Don't forget to subscribe to our newsletter and blog!